Clincosm LogoSign in Get a demo

prostatic neoplasms

Showing NaN - NaN of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About Novel Hormonal Therapies for Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Nov 21, 2023

Learn About Novel Hormonal Therapies in People With Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Oct 2, 2023

Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)

Not yet recruiting
  • Prostatic Neoplasms
  • Mineola, New York
  • +14 more
Aug 23, 2023

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

Recruiting
  • Prostate Cancer
  • +5 more
  • 177Lu-rhPSMA-10.1 injection
  • 18F-rhPSMA-7.3 injection
  • Glen Burnie, Maryland
  • +3 more
Feb 2, 2023

Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)

Recruiting
  • Prostatic Neoplasms
  • +16 more
  • Birmingham, Alabama
  • +296 more
Jan 18, 2023

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • Duarte, California
  • +9 more
Nov 15, 2022

Prostatic Tumors Trial in New York, Myrtle Beach, Houston (ORIC-101, enzalutamide 40 MG oral capsule [Xtandi])

Active, not recruiting
  • Prostatic Neoplasms
  • ORIC-101
  • enzalutamide 40 MG oral capsule [Xtandi]
  • New York, New York
  • +2 more
Sep 22, 2022

Prostatic Tumors Trial in United States (CC-94676)

Recruiting
  • Prostatic Neoplasms
  • Birmingham, Alabama
  • +30 more
Aug 17, 2022

Prostatic Tumors Trial in Worldwide (Niraparib)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Tucson, Arizona
  • +109 more
Aug 2, 2022

Prostatic Tumors, Prostate Tumors, Prostate Cancer Trial in New York (5-Azacitidine, all trans retinoic acid, Lupron)

Completed
  • Prostatic Neoplasms
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 1, 2022

Prostatic Tumors, Adenocarcinoma Trial in United States (JNJ-69086420)

Recruiting
  • Prostatic Neoplasms
  • Adenocarcinoma
  • Duarte, California
  • +7 more
Aug 2, 2022

Prostatic Tumors Trial in United States (JNJ-75229414, Bridging Therapy)

Recruiting
  • Prostatic Neoplasms
  • Duarte, California
  • +10 more
Aug 2, 2022

Prostatic Tumors Trial in New York (CC-90011, Abiraterone, Prednisone)

Recruiting
  • Prostatic Neoplasms
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 21, 2022

Prostatic Tumors Trial in New York (18F- DCFPyL PET/CT)

Active, not recruiting
  • Prostatic Neoplasms
  • 18F- DCFPyL PET/CT
  • New York, New York
    Columbia University Irving Medical Center
May 6, 2022

Ascertainment of Peripheral Blood or Saliva Samples for Genetic

Active, not recruiting
  • Breast Neoplasms
  • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 14, 2021

    Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

    Completed
    Has Results
    • Advanced Prostate Cancer
    • Prostatic Neoplasms
    • sipuleucel-T
    • Bessemer, Alabama
    • +332 more
    Mar 5, 2019

    Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, mitoxantrone, prednisone)

    Terminated
    Has Results
    • Prostate Cancer
    • +3 more
    • Scottsdale, Arizona
    • +81 more
    Apr 23, 2018

    Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, prednisone)

    Completed
    Has Results
    • Prostate Cancer
    • +3 more
    • Birmingham, Alabama
    • +263 more
    Feb 14, 2018

    Prostate Cancer, Prostatic Tumors Trial in United States (Panobinostat, Bicalutamide)

    Completed
    Has Results
    • Prostate Cancer
    • Prostatic Neoplasms
    • New Brunswick, New Jersey
    • +3 more
    Jan 10, 2018

    Prostatic Tumors Trial in Worldwide (Placebo, Dasatinib, Docetaxel)

    Completed
    Has Results
    • Prostatic Neoplasms
    • Placebo
    • +3 more
    • Mobile, Alabama
    • +185 more
    Aug 23, 2016

    Prostate Cancer, Prostatic Tumors Trial in New York (Docetaxel, Imatinib Mesylate)

    Terminated
    Has Results
    • Prostate Cancer
    • Prostatic Neoplasms
    • New York, New York
    • +2 more
    May 31, 2016

    Prostatic Tumors Trial in United States (Radium-223 dichloride (BAY88-8223))

    No longer available
    • Prostatic Neoplasms
    • Radium-223 dichloride (BAY88-8223)
    • Birmingham, Alabama
    • +59 more
    Jul 11, 2014

    Prostatic Tumors Trial in United States (CNTO 328, Docetaxel)

    Completed
    • Prostatic Neoplasms
    • Baltimore, Maryland
    • +4 more
    May 23, 2014

    Prostatic Tumors Trial in Worldwide (Placebo, Abiraterone acetate, Prednisone/prednisolone)

    Completed
    Has Results
    • Prostatic Neoplasms
    • Placebo
    • +2 more
    • Birmingham, Alabama
    • +127 more
    Apr 10, 2014